Ipamorelin 5mg

Ipamorelin 5mg Research Peptide

Ipamorelin is a synthetic peptide investigated as a growth-hormone-secretagogue-receptor agonist and supplied exclusively for laboratory and in vitro research.

The compound is relevant to experimental models examining GHSR activation, peptide-receptor selectivity, endocrine signalling and downstream growth-hormone-associated pathways.

Published investigations remain experimental and do not establish suitability, safety or effectiveness for human or veterinary use.

Original Ipamorelin research

The original 1998 Ipamorelin pharmacology paper describes a pentapeptide and investigations in laboratory and animal models. It provides context for the secretagogue research above; it does not establish the specification of this 5mg product.

For product selection, distinguish this single-compound listing from the two-component blend below. Match identity and batch records to the selected material, and assess the components separately when reviewing published evidence.

Review available product and batch documentation. Coverage varies; check that the record matches the material you are considering.

---

Research Areas

• GHSR activation research
• Peptide-receptor selectivity studies
• Endocrine-signalling investigations
• Growth-hormone-associated pathways
• Neuroendocrine research models

---

Compare Single-Compound and Blend Listings

This listing contains Ipamorelin 5mg. The separate CJC-1295 (No DAC) and Ipamorelin blend contains two compounds, at 5mg each. Compare the composition with your experimental requirements and consult the available product documentation.

Important Research Use Notice

This product is supplied strictly for laboratory and in vitro research purposes only.
Not for human consumption.
Not for veterinary use.
Not for medical, therapeutic, diagnostic or administration purposes.